eloralintide vs tirzepatide Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial Amylin: The Forgotten Pancreatic Hormone

While they typically improve over time, their impact on hydration status can be significant

The rationale is appealing on paper

The mechanisms driving them are the same ones improving insulin sensitivity and reducing body weight

At this stage, many patients continue to see improvements in: Blood sugar control Blood pressure Lipids Inflammation markers which lower cardiovascular risk Mobility and quality of life Focusing only on the scale can miss these meaningful health gains

Adverse events linked to compounded GLP-1s include redness, site swelling, pain, and a red lump at the injection site, according to the FDA

When combined with nutrition, non-invasive treatments, and lifestyle coaching at Unicorn Medi Spa, it provides safe, effective, and sustainable results